In Brief: Tylenol ads
This article was originally published in The Tan Sheet
Executive Summary
Tylenol ads: McNeil is running a television ad campaign in response to a study in the Dec. 22 issue of the New England Journal of Medicine, which found an increased risk of kidney disease among medium to heavy users of acetaminophen ("The Tan Sheet" Jan. 2, p. 7). Two spots feature female spokespersons of different ages telling viewers that their doctors recommend Tylenol and it is the brand they trust. The length of the campaign, which began Dec. 31, will depend on the results of consumer research, the company said. Saatchi & Saatchi is handling the ad campaign...
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning